Gateway Genomics Ranks 236 in the Inc. 500 Fastest-Growing Private Companies in America List for 2019

August 14, 2019

Gateway Genomics is the 23rd fastest growing company in the Health sector, which includes biotech, pharmaceutical firms, and makers of medical devices and products for the health care market.


Breakthrough Publication Shows Gateway Genomics SneakPeek Early Gender DNA Blood Test Identifies Fetal Sex at 8 Weeks into Pregnancy with 99.1% Accuracy

July 18, 2019

SneakPeek lets parents learn their baby’s gender earlier than any other available method, weeks earlier than non-invasive parental tests (NIPTs) and months earlier than standard anatomy scan ultrasounds.


Gateway Genomics Achieves Milestone of 100,000 SneakPeek Early Gender DNA Tests Sold

June 3, 2019

Growth accelerates as company increases domestic and international brand awareness and expands clinical market.


Gateway Genomics Announces Expanding Office and Research Space to Accommodate Increased Demand for SneakPeek DNA Test

May 14, 2019

LA JOLLA, Calif.--(PRWeb)--Gateway Genomics, a leading developer of prenatal and pediatric genetic tests, announces an office expansion, effectively doubling its space from 2,500 to 5,000 square feet.


Gateway Genomics SneakPeek Noninvasive Prenatal Test (NIPT) Identifies Gender with Cell-free Fetal DNA from Microvolumes of Self-collected Maternal Blood

May 1, 2019

LA JOLLA, Calif.--(PRWeb)--Gateway Genomics, a leading developer of genomic tests that give families insight into their future children, announces a new publication titled, “Self-Collection of Maternal Blood for Fetal Sex Determination Using Cell-Free DNA” in the journal of Pregnancy and Child Health…


SneakPeek Clinical Greater Than 99% Accurate for Fetal Sex at 9 Weeks into Pregnancy – SneakPeek Early Gender Test Results Published in Journal of Pregnancy and Child Health

February 27, 2018

LA JOLLA, Calif.--(BUSINESS WIRE)--The Journal of Pregnancy and Child Health published a SneakPeek Clinical study that is exciting news for low-risk pregnant women seeking to know the gender of their baby. Typically, only high-risk pregnancies are eligible for insurance coverage for prescription-based NIPTs. As for everyone else, the cost of entry can be in the thousands. With this new publication, SneakPeek proves that no longer has to be…


Gateway Genomics Launches SneakPeek® Early Gender Test and Shifts NIPT Testing to a Highly Affordable, Easy to Use At-Home Version

October 8, 2015

Gateway Genomics demonstrates the accuracy of its advanced prenatal technology in a validation study showcased at the American Society of Human Genetics Conference. After previously overcoming a twenty-year roadblock of current non-invasive maternal venous blood collection by proving it is possible to accurately determine gender from maternal capillary blood, they have now made the technology available to the public in an at-home test…